-
Mashup Score: 2
TRILUMINATE, the first pivotal trial of a device for repair of severe tricuspid regurgitation, showed a large reduction in valve dysfunction associated with substantial improvement in quality of life.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Pivotal trial is first to evaluate ‘impact of TR reduction on long-term effects on survival’
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Program Planner - 1 year(s) ago
Program Planner One fine body�
Source: www.abstractsonline.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
BOSTON — A novel mitral valve transcatheter edge-to-edge repair system was noninferior to an existing system in a head-to-head trial in patients with severe symptomatic degenerative mitral regurgitation, researchers reported at TCT 2022.For the CLASP IID trial, researchers compared the novel system (Pascal, Edwards Lifesciences) with the existing system (MitraClip, Abbott). As Healio
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
The results suggest the approach could help alleviate worldwide shortages of blood products, P.J. Devereaux says.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Request for Nominations for Voting Members on Public Advisory Panels of the Medical Devices Advisory Committee - 2 year(s) ago
The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Medical Devices Advisory Committee (MDAC) device panels in the Center for Devices and Radiological Health. This annual notice is also in accordance with the 21st Century Cures Act, which requires…
Source: Federal RegisterCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The single-center, proof-of-concept study sets the stage for a larger trial to quantify the potential benefit, Mario Gaudino says.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Cardiac Surgery Team Section - American College of Cardiology - 2 year(s) ago
The ACC’s Cardiac Surgery Team Member Section and Leadership Council is the home for all members of the cardiac surgery heart team within the ACC, advocating for and advancing the priorities of the community.
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
While you're waiting for the next #AHA21 session, "Valves, Veins and New Viewpoints in Cardiothoracic Surgery," find helpful resources for the entire 💗 surgery team on the ACC's Cardiac Surgery Team Section page. Check it out here 🔎 https://t.co/wYgvllcZ34 #ACCSurgeons #cvSurg https://t.co/xftzFbLRq8
-
-
Mashup Score: 5Visual Abstract | FAME 3 - American College of Cardiology - 2 year(s) ago
The Image and Slide Gallery captures images, videos, or slides which can serve as useful teaching materials in the field of CV medicine.
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
I suspect many of us have grown weary of hearing about what ISCHEMIA, COURAGE, those fractional flow reserve (FFR) trials, and CIAO (see below if that trial escaped you) tell us about best therapeutic strategies for coronary artery disease (CAD). That is not what this editorial is about. As I think about these trials, I can’t rid myself of some…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
According to the TRILUMINATE trial, TEER improved outcomes with #vhdTR. Dr. @KendraGrubb commented on the trial findings during an #ACC23/#WCCardio press conference. Find out more in @Medscape: https://t.co/NCnY0ZBnYt #ACCSurgeons #cvSurg